ClinicalTrials.Veeva

Menu

Investigation of Adults With Congenital Heart Disease in the Scope of the ICF

H

Hacettepe University

Status

Enrolling

Conditions

Quality of Life
ICF
Congenital Heart Disease

Treatments

Other: Physiotherapy assessment

Study type

Observational

Funder types

Other

Identifiers

NCT05774158
03032023

Details and patient eligibility

About

Congenital heart disease (CHD) is one of the common birth defects with a prevalence of approximately 1 in 1000 live births worldwide. While 15% of patients with CHD reached adulthood in the past, this rate is close to 90% today thanks to advancing medicine and technology.As individuals with CHD age, they may be affected by acquired cardiovascular risk factors common in the general population in addition to heart diseases such as arterial hypertension, obesity, and diabetes, increasing the risk of metabolic disease, stroke, and coronary artery disease. In addition to these risk factors, the disease affects both the social and familial environment of the patients. In addition to the mortality and morbidity of patients, which was the most important outcome measure in the past, quality of life has become the subject of current research. The International Classification of Functioning and Health (ICF) was adopted in 2001 for the use of a common, standard language and framework for describing health and health-related conditions, and is an international and standardized classification system that can evaluate functioning, disability and health holistically. There are no studies in the literature evaluating body structure, function and activity and participation in adults with congenital heart disease within the scope of ICF. Therefore, the aim of this study is; It is the evaluation of adults with CHD according to ICF sub-parameters (body structure and functions, activity and participation, and environmental factors) and the correlation of ICF parameters with other evaluation methods.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosed with congenital heart disease
  • Being between the ages of 18-65
  • To have been informed about the study and given written consent to participate in the study.

Exclusion criteria

  • Having a neurological, orthopedic or any systemic disease,
  • Presence of infection and malignancy,
  • Cognitive, psychological and mental status are not suitable for evaluations,
  • To undergo another surgery other than cardiac surgery.

Trial design

30 participants in 1 patient group

Adult Congenital Heart Diseases
Treatment:
Other: Physiotherapy assessment

Trial contacts and locations

1

Loading...

Central trial contact

Tuğba Siyah

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems